Some plasmin-induced antibodies bind to cardiolipin, display lupus anticoagulant activity and induce fetal loss in mice

Journal of Immunology

Volumn 178, Issue 8, 2007, Pages 5351-5356

  Chen, Xiao Xiang ^a   Gu, Yue Ying ^a   Li, Shu Jie ^a   Qian, Jie ^a   Hwang, Kwan Ki ^b   Chen, Pojen P ^b   Chen, Shun Le ^a   Yang, Cheng De ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G ANTIBODY; LUPUS ANTICOAGULANT; PLASMIN; PLASMIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BAGG ALBINO MOUSE; COMPLEMENT DEPOSITION; CONTROLLED STUDY; FETUS; FETUS WASTAGE; IMMUNIZATION; IMMUNOHISTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOSIS;

EID: 34247153549     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.8.5351     Document Type: Article

References (39)

1. Levine, J. S., D. W. Branch, and J. Rauch. 2002. The antiphospholipid syndrome. N. Engl. J. Med. 346: 752-763.
2. Merrill, J. T. 2004. Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus. Lupus 13: 869-876.
3. Erkan, D., and M. D. Lockshin. 2004. What is antiphospholipid syndrome? Curr. Rheumatol. Rep. 6: 451-457.
4. Cugno, M., M. Cabibbe, M. Galli, P. L. Meroni, S. Caccia, R. Russo, B. Bottasso, and P. M. Mannucci. 2004. Antibodies to tissue-type plasminogen activator (t-PA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients. Blood 103: 2121-2126.
5. Lu, C. S., A. A. Horizon, K. K. Hwang, J. FitzGerald, W. S. Lin, B. H. Hahn, D. J. Wallace, A. Metzger, M. H. Weisman, and P. P. Chen. 2005. Identification of polyclonal and monoclonal antibodies against tissue-type plasminogen activator in the antiphospholipid syndrome. Arthritis Rheum. 52: 4018-4027.
6. Hwang, K. K., J. M. Grossman, S. Visvanathan, R. U. Chukwuocha, V. L. Woods, D. T. Le, B. H. Hahn, and P. P. Chen. 2001. Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin. J. Immunol. 167: 7192-7198.
7. Hwang, K. K., C. D. Yang, W. Yan, J. M. Grossman, B. H. Hahn, and P. P. Chen. 2003. A thrombin-cross-reactive anticardiolipin antibody binds to and inhibits the anticoagulant function of activated protein C. Arthritis Rheum. 48: 1622-1630.
8. Yang, C. D., K. K. Hwang, W. Yan, K. Gallagher, J. FitzGerald, J. M. Grossman, B. H. Hahn, and P. P. Chen. 2004. Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin. J. Immunol. 172: 5765-5773.
9. Boumsell, L., and A. Bernard. 1980. High efficiency of Biozzi's high responder mouse strain in the generation of antibody secreting hybridomas. J. Immunol. Methods 38: 225-229.
10. Askonas, B. A., A. J. McMichael, and M. E. Roux. 1976. Clonal dominance and the preservation of clonal memory cells mediated by antigen-antibody, Immunology 31:541-551.
11. Loizou, S., J. D. McCrea, A. C. Rudge, R. Reynolds, C. C. Boyle, and E. N. Harris. 1985. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin. Exp. Immunol. 62: 738-745.
12. Wang, Y., L. Schrieber, M. G. Cohen, L. Furphy, J. Webb, T. Chivers, and K. M. Pollard. 1990. Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients. Rheumatol. Int. 10: 75-80.
13. Zhu, M., T. Olee, D. T. Le, R. A. S. Roubey, B. H. Hahn, V. L. Woods, Jr., and P. P. Chen. 1999. Characterization of IgG monoclonal anti-cardiolipin/antiβ2GP1 antibodies from two patients with the anti-phospholipid syndrome reveals three species of antibodies. Br. J. Haematol. 105: 102-109.
14. Exner, T., K. A. Rickard, and H. Kronenberg. 1978. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br. J. Haematol. 40: 143-151.
15. Coleman, J. L., T. J. Sellati, J. E. Testa, R. R. Kew, M. B. Furie, and J. L. Benach, 1995. Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers. Infect. Immun. 63: 2478-2484.
16. Vogt, E., A. K. Ng, and N. S. Rote. 1996. A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am. J. Obstet. Gynecol. 174: 700-707.
17. Gharavi, A. E., M. Vega-Ostertag, R. G. Espinola, X. Liu, L. Cole, N. T. Cox, P. Romagnoli, K. Labat, and S. S. Pierangeli. 2004. Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies. Lupus 13: 17-23.
18. Berman, J., G. Girardi, and J. E. Salmon. 2005. TNF-α is a critical effector and a target for therapy in antiphospholipid antibody-induced- pregnancy loss. J. Immunol. 174: 485-490.
19. Pierangeli, S. S., X. W. Liu, R. Espinola, T. Olee, M. Zhu, N. E. Harris, and P. P. Chen. 2000. Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb. Haemost. 84: 388-395.
20. Holers, V. M., G. Girardi, L. Mo, J. M. Guthridge, H. Molina, S. S. Pierangeli, R. Espinola, L. E. Xiaowei, D. Mao, C. G. Vialpando, and J. E. Salmon. 2002. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J. Exp. Med. 195: 211-220.
21. Puurunen, M., T. Palosuo, R. Lassila, M. Anttilla, and O. Vaarala. 2001. Immunologic and hematologic properties of antibodies to prothrombin and plasminogen in a mouse model. Lupus 10: 108-115.
22. Tincani, A., G. Balestrieri, E. Danieli, D. Faden, A. Lojacono, B. Acaia, L. Trespidi, D. Ventura, and P. L. Meroni. 2003. Pregnancy complications of the antiphospholipid syndrome. Autoimmunity 36: 27-32.
23. Blank, M., J. Cohen, V. Toder, and Y. Shoenfeld. 1991. Induction of antiphos-pholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc. Natl. Acad. Sci. USA 88: 3069-3073.
24. Branch, D. W., D. J. Dudley, M. D. Mitchell, K. A. Greighton, T. M. Abbott, E. H. Hammon, and R. A. Baynes. 1990. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am. J. Obstet. Gynecol. 163: 210-216.
25. Blank, M., A. Tincani, and Y. Shoenfeld. 1994. Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J. Rheumatol. 21: 100-104.
26. 2-glycoprotein-1 on trophoblast proliferation as a mechanism of fetal death. Lancet 352: 1037-1038.
27. Di Simone, N., R. Castellani, D. Caliandro, and A. Caruso. 2001. Monoclonal anti-annexin V antibody inhibit trophoblast gonadotrophin secretion and induces syncytiotrophoblast apoptosis. Biol. Reprod. 65: 1766-1770.
28. Pellis, V., F. De Seta, S. Crovella, F. Bossi, R. Bulla, S. Guaschino, O. Radillo, P. Garred, and F. Tedesco. 2005. Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina. Clin. Exp. Immunol. 139: 120-126.
29. McCrae, K. R., A. M. DeMichele, P. Pandhi, M. J. Balsai, P. Samuels, C. Graham, P. K. Lala, and D. B. Cines. 1993. Detection of antitrophoblast antibodies in the sera of patients with anticardiolipin antibodies and fetal loss. Blood 82: 2730-2741.
30. Rand, J. H., X. X. Wu, H. A. Andree, C. J. Lockwood, S. Guller, J. Scher, and P. C. Harpel. 1997. Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. N. Engl. J. Med. 337: 154-160.
31. Fakhouri, F., L. H. Noel, J. Zuber, H. Beaufils, F. Martinez, P. Lebon, T. Papo, D. Chauveau, O. Bletry, J. P. Grunfeld, et al. 2003. The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am. J. Kidney Dis. 41: 1205-1211.
32. Korkmaz, C., S. Kabukcuoglu, S. Isiksoy, and A. U. Yalcin. 2003. Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy. Lupus 12: 760-765.
33. Piette, J. C., P. Cacoub, and B. Wechsler. 1994. Renal manifestations of the antiphospholipid syndrome. Semin. Arthritis Rheum. 23: 357-366.
34. Nochy, D., E. Daugas, D. Droz, H. Beaufils, J. P. Grunfeld, J. C. Piette, J. Bariety, and G. Hill. 1999. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J. Am. Soc. Nephrol. 10: 507-518.
35. Lahteenmaki, K., P. Kuusela, and T. K. Korhonen. 2001. Bacterial plasminogen activators and receptors. FEMS Microbiol. Rev. 25: 531-552.
36. Sun, H., U. Ringdahl, J. W. Homeister, W. P. Fay, N. C. Engleberg, A. Y. Yang, L. S. Rozek, X. Wang, U. Sjobring, and D. Ginsburg. 2004. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305: 1283-1286.
37. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12: 991-1045.
38. Gallucci, S., and P. Matzinger. 2001. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13: 114-119.
39. Wilson, W. A., A. E. Gharavi, T. Koike, M. D. Lockshin, D. W. Branch, J. C. Piette, R. Brey, R. Derksen, E. N. Harris, G. R. Hughes, D. A. Triplett, and M. A. Khamashta. 1999. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 42: 1309-1311.